Eric Adjei Boakye1,2, Nosayaba Osazuwa-Peters3,4, Julia López5, Vy T Pham3, Betelihem B Tobo6, Leping Wan7, Mario Schootman8, Jane A McElroy9. 1. Department of Population Science and Policy, Southern Illinois University School of Medicine , Springfield, IL, USA. 2. Simmons Cancer Institute, Southern Illinois University School of Medicine , Springfield, IL, USA. 3. Department of Otolaryngology-Head and Neck Surgery, Saint Louis University School of Medicine , St. Louis, MO, USA. 4. Saint Louis University Cancer Center , Saint Louis, MO, USA. 5. Department of Obstetrics & Gynecology, Washington University School of Medicine , St. Louis, MO, USA. 6. Community Health Administration, DC Health , Washington, DC, USA. 7. Department of Radiation Oncology, Washington University School of Medicine , St. Louis, MO, USA. 8. Center for Clinical Excellence, SSM Health , Saint Louis, MO, USA. 9. Family and Community Medicine Department, University of Missouri , Columbia, MO, USA.
Abstract
OBJECTIVES: We compared HPV vaccine initiation and completion of heterosexual with lesbian and bisexual (LB) women. METHODS: We aggregated National Health and Nutrition Examination Survey data from 2009 to 2016 for 3,017 women aged 18 to 34 y in the United States. HPV vaccine initiation was defined as reported receipt of ≥1 dose of the vaccine and completion as receipt of the three recommended doses. Weighted percentages and multivariable logistic regression models were used to examine differences in HPV vaccine initiation and completion between heterosexual and LB women. RESULTS: Approximately 12% of respondents self-identified as LB women. Overall, a higher percentage of respondents (26%) had initiated the HPV vaccine than completed the three vaccine doses (17%). In the bivariate analysis, LB women had higher initiation ([35% of LB women versus 25% heterosexual]; p = .0012) and completion rates ([24% of LB women versus 17% heterosexual]; p = .0052) than heterosexual women. After adjusting for covariates, compared to heterosexual women, LB women were 60% (aOR = 1.60, 95% CI: 1.16-2.19) more likely to initiate and 63% (aOR = 1.63, 95% CI: 1.12-2.37) more likely to complete the HPV vaccine. CONCLUSIONS: Although LB women had higher likelihood of HPV vaccine initiation and completion compared with heterosexual women, their HPV vaccine uptake was well below the Healthy People 2020 target (80%). Understanding differences in the drivers of vaccine uptake in the LB population may inform strategies that would further increase HPV vaccine uptake toward achieving the 80% completion target.
OBJECTIVES: We compared HPV vaccine initiation and completion of heterosexual with lesbian and bisexual (LB) women. METHODS: We aggregated National Health and Nutrition Examination Survey data from 2009 to 2016 for 3,017 women aged 18 to 34 y in the United States. HPV vaccine initiation was defined as reported receipt of ≥1 dose of the vaccine and completion as receipt of the three recommended doses. Weighted percentages and multivariable logistic regression models were used to examine differences in HPV vaccine initiation and completion between heterosexual and LBwomen. RESULTS: Approximately 12% of respondents self-identified as LBwomen. Overall, a higher percentage of respondents (26%) had initiated the HPV vaccine than completed the three vaccine doses (17%). In the bivariate analysis, LBwomen had higher initiation ([35% of LBwomen versus 25% heterosexual]; p = .0012) and completion rates ([24% of LBwomen versus 17% heterosexual]; p = .0052) than heterosexual women. After adjusting for covariates, compared to heterosexual women, LBwomen were 60% (aOR = 1.60, 95% CI: 1.16-2.19) more likely to initiate and 63% (aOR = 1.63, 95% CI: 1.12-2.37) more likely to complete the HPV vaccine. CONCLUSIONS: Although LBwomen had higher likelihood of HPV vaccine initiation and completion compared with heterosexual women, their HPV vaccine uptake was well below the Healthy People 2020 target (80%). Understanding differences in the drivers of vaccine uptake in the LB population may inform strategies that would further increase HPV vaccine uptake toward achieving the 80% completion target.
Entities:
Keywords:
HPV vaccination initiation and completion; HPV vaccine; Human papillomavirus; lesbian and bisexual women; sexual orientation; young adults
Authors: Madina Agénor; Nancy Krieger; S Bryn Austin; Sebastien Haneuse; Barbara R Gottlieb Journal: Am J Public Health Date: 2013-12-12 Impact factor: 9.308
Authors: Brittany M Charlton; Heather L Corliss; Stacey A Missmer; A Lindsay Frazier; Margaret Rosario; Jessica A Kahn; S Bryn Austin Journal: J Adolesc Health Date: 2011-06-08 Impact factor: 5.012
Authors: Eric Adjei Boakye; Betelihem B Tobo; Nosayaba Osazuwa-Peters; Kahee A Mohammed; Christian J Geneus; Mario Schootman Journal: Am J Prev Med Date: 2016-11-24 Impact factor: 5.043
Authors: Maggie Wang; Arun Sharma; Nosayaba Osazuwa-Peters; Matthew C Simpson; Mario Schootman; Jay F Piccirillo; Warner K Huh; Eric Adjei Boakye Journal: Cancer Epidemiol Date: 2019-12-06 Impact factor: 2.984